Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease

This publication has 23 references indexed in Scilit:

• Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)
  The American Journal of Cardiology, 1993
• The influence of sex and diabetes mellitus on survival following acute myocardial infarction: A community-wide perspective
  Journal of Clinical Epidemiology, 1993
• Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor
  The American Journal of Cardiology, 1988
• Mortality and Morbidity During a Five‐year Follow‐up of Diabetics with Myocardial Infarction
  Acta Medica Scandinavica, 1988
• Myocardial infarction in the diabetic patient
  Clinical Cardiology, 1985
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985
• Diabetes as an atherogenic factor
  Progress in Cardiovascular Diseases, 1984
• Influence of Beta‐Blocking Drugs on Glucose Metabolism in Patients with Non‐Insulin Dependent Diabetes Mellitus
  Acta Medica Scandinavica, 1982
• Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.
  BMJ, 1979
• Metabolic Effects of β-Adrenoreceptor Blockers
  Drugs, 1976